{"id": "train_2_76", "text": "Our work supported @GENE$ genetic variants as possible susceptibility factors for @DISEASE$ and fractures in humans.", "text_with_entity_marker": "Our work supported [E1]@GENE$[/E1] genetic variants as possible susceptibility factors for [E2]@DISEASE$[/E2] and fractures in humans.", "text_with_typed_entity_marker": "Our work supported [GENE]@GENE$[/GENE] genetic variants as possible susceptibility factors for [DISEASE]@DISEASE$[/DISEASE] and fractures in humans.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [19, 25], "entity_1_idx_in_text_with_entity_marker": [23, 29], "entity_1_idx_in_text_with_typed_entity_marker": [25, 31], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [82, 91], "entity_2_idx_in_text_with_entity_marker": [95, 104], "entity_2_idx_in_text_with_typed_entity_marker": [104, 113], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_2_84", "text": "In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (@GENE$; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with @DISEASE$.", "text_with_entity_marker": "In the case-control association analysis, the g.-247C/T polymorphism at the promoter region ([E1]@GENE$[/E1]; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "In the case-control association analysis, the g.-247C/T polymorphism at the promoter region ([GENE]@GENE$[/GENE]; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [93, 99], "entity_1_idx_in_text_with_entity_marker": [97, 103], "entity_1_idx_in_text_with_typed_entity_marker": [99, 105], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [229, 238], "entity_2_idx_in_text_with_entity_marker": [242, 251], "entity_2_idx_in_text_with_typed_entity_marker": [251, 260], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_2_267", "text": "The K121Q variant of @GENE$ may be associated with @DISEASE$ viremia and core antigen levels in HCV carriers.", "text_with_entity_marker": "The K121Q variant of [E1]@GENE$[/E1] may be associated with [E2]@DISEASE$[/E2] viremia and core antigen levels in HCV carriers.", "text_with_typed_entity_marker": "The K121Q variant of [GENE]@GENE$[/GENE] may be associated with [DISEASE]@DISEASE$[/DISEASE] viremia and core antigen levels in HCV carriers.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [21, 27], "entity_1_idx_in_text_with_entity_marker": [25, 31], "entity_1_idx_in_text_with_typed_entity_marker": [27, 33], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [51, 60], "entity_2_idx_in_text_with_entity_marker": [64, 73], "entity_2_idx_in_text_with_typed_entity_marker": [73, 82], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_2_198", "text": "The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and @GENE$, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in @DISEASE$.", "text_with_entity_marker": "The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and [E1]@GENE$[/E1], in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and [GENE]@GENE$[/GENE], in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [73, 79], "entity_1_idx_in_text_with_entity_marker": [77, 83], "entity_1_idx_in_text_with_typed_entity_marker": [79, 85], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [325, 334], "entity_2_idx_in_text_with_entity_marker": [338, 347], "entity_2_idx_in_text_with_typed_entity_marker": [347, 356], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_2_293", "text": "The HBS1L-MYB intergenic region on chromosome @GENE$ is a quantitative trait locus controlling fetal haemoglobin level in carriers of @DISEASE$.", "text_with_entity_marker": "The HBS1L-MYB intergenic region on chromosome [E1]@GENE$[/E1] is a quantitative trait locus controlling fetal haemoglobin level in carriers of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "The HBS1L-MYB intergenic region on chromosome [GENE]@GENE$[/GENE] is a quantitative trait locus controlling fetal haemoglobin level in carriers of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [46, 52], "entity_1_idx_in_text_with_entity_marker": [50, 56], "entity_1_idx_in_text_with_typed_entity_marker": [52, 58], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [134, 143], "entity_2_idx_in_text_with_entity_marker": [147, 156], "entity_2_idx_in_text_with_typed_entity_marker": [156, 165], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_2_156", "text": "The OR of the @GENE$ in our pediatric study is highly comparable with that reported previously in a non-Jewish adult @DISEASE$ case-control cohort (OR, 0.26).", "text_with_entity_marker": "The OR of the [E1]@GENE$[/E1] in our pediatric study is highly comparable with that reported previously in a non-Jewish adult [E2]@DISEASE$[/E2] case-control cohort (OR, 0.26).", "text_with_typed_entity_marker": "The OR of the [GENE]@GENE$[/GENE] in our pediatric study is highly comparable with that reported previously in a non-Jewish adult [DISEASE]@DISEASE$[/DISEASE] case-control cohort (OR, 0.26).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [14, 20], "entity_1_idx_in_text_with_entity_marker": [18, 24], "entity_1_idx_in_text_with_typed_entity_marker": [20, 26], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [117, 126], "entity_2_idx_in_text_with_entity_marker": [130, 139], "entity_2_idx_in_text_with_typed_entity_marker": [139, 148], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_2_45", "text": "In the case-control association analysis, the @GENE$ polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with @DISEASE$.", "text_with_entity_marker": "In the case-control association analysis, the [E1]@GENE$[/E1] polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "In the case-control association analysis, the [GENE]@GENE$[/GENE] polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [46, 52], "entity_1_idx_in_text_with_entity_marker": [50, 56], "entity_1_idx_in_text_with_typed_entity_marker": [52, 58], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [230, 239], "entity_2_idx_in_text_with_entity_marker": [243, 252], "entity_2_idx_in_text_with_typed_entity_marker": [252, 261], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_2_288", "text": "The @GENE$ SNP could be considered as a genetic marker to predict the clinical course of patients suffering from oropharyngeal and @DISEASE$.", "text_with_entity_marker": "The [E1]@GENE$[/E1] SNP could be considered as a genetic marker to predict the clinical course of patients suffering from oropharyngeal and [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] SNP could be considered as a genetic marker to predict the clinical course of patients suffering from oropharyngeal and [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [131, 140], "entity_2_idx_in_text_with_entity_marker": [144, 153], "entity_2_idx_in_text_with_typed_entity_marker": [153, 162], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_2_53", "text": "@GENE$, IL-1R and TNFalpha gene polymorphisms in Iranian patients with @DISEASE$.", "text_with_entity_marker": "[E1]@GENE$[/E1], IL-1R and TNFalpha gene polymorphisms in Iranian patients with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE], IL-1R and TNFalpha gene polymorphisms in Iranian patients with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [71, 80], "entity_2_idx_in_text_with_entity_marker": [84, 93], "entity_2_idx_in_text_with_typed_entity_marker": [93, 102], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_2_220", "text": "Especially, the SNP @GENE$ and its strongly associated SNPs (e.g., rs1784235) could be important to human @DISEASE$ phenotypes.", "text_with_entity_marker": "Especially, the SNP [E1]@GENE$[/E1] and its strongly associated SNPs (e.g., rs1784235) could be important to human [E2]@DISEASE$[/E2] phenotypes.", "text_with_typed_entity_marker": "Especially, the SNP [GENE]@GENE$[/GENE] and its strongly associated SNPs (e.g., rs1784235) could be important to human [DISEASE]@DISEASE$[/DISEASE] phenotypes.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [20, 26], "entity_1_idx_in_text_with_entity_marker": [24, 30], "entity_1_idx_in_text_with_typed_entity_marker": [26, 32], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [106, 115], "entity_2_idx_in_text_with_entity_marker": [119, 128], "entity_2_idx_in_text_with_typed_entity_marker": [128, 137], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_2_268", "text": "Vitamin D receptor (@GENE$) genotypes may influence cancer risk; however, no epidemiological studies in @DISEASE$ (BC) or malignant melanoma (MM) have been performed in a southern European population.", "text_with_entity_marker": "Vitamin D receptor ([E1]@GENE$[/E1]) genotypes may influence cancer risk; however, no epidemiological studies in [E2]@DISEASE$[/E2] (BC) or malignant melanoma (MM) have been performed in a southern European population.", "text_with_typed_entity_marker": "Vitamin D receptor ([GENE]@GENE$[/GENE]) genotypes may influence cancer risk; however, no epidemiological studies in [DISEASE]@DISEASE$[/DISEASE] (BC) or malignant melanoma (MM) have been performed in a southern European population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [20, 26], "entity_1_idx_in_text_with_entity_marker": [24, 30], "entity_1_idx_in_text_with_typed_entity_marker": [26, 32], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [104, 113], "entity_2_idx_in_text_with_entity_marker": [117, 126], "entity_2_idx_in_text_with_typed_entity_marker": [126, 135], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_2_295", "text": "To assess clinical significance, 93 @DISEASE$ lesions were evaluated for expression of VEGF and @GENE$ by immunohistochemistry.", "text_with_entity_marker": "To assess clinical significance, 93 [E1]@DISEASE$[/E1] lesions were evaluated for expression of VEGF and [E2]@GENE$[/E2] by immunohistochemistry.", "text_with_typed_entity_marker": "To assess clinical significance, 93 [DISEASE]@DISEASE$[/DISEASE] lesions were evaluated for expression of VEGF and [GENE]@GENE$[/GENE] by immunohistochemistry.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [36, 45], "entity_1_idx_in_text_with_entity_marker": [40, 49], "entity_1_idx_in_text_with_typed_entity_marker": [45, 54], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [96, 102], "entity_2_idx_in_text_with_entity_marker": [109, 115], "entity_2_idx_in_text_with_typed_entity_marker": [121, 127], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_2_141", "text": "Our data provide the first evidence that the @GENE$ polymorphism is associated with decreased risk of @DISEASE$.", "text_with_entity_marker": "Our data provide the first evidence that the [E1]@GENE$[/E1] polymorphism is associated with decreased risk of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Our data provide the first evidence that the [GENE]@GENE$[/GENE] polymorphism is associated with decreased risk of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [45, 51], "entity_1_idx_in_text_with_entity_marker": [49, 55], "entity_1_idx_in_text_with_typed_entity_marker": [51, 57], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [102, 111], "entity_2_idx_in_text_with_entity_marker": [115, 124], "entity_2_idx_in_text_with_typed_entity_marker": [124, 133], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_2_96", "text": "Finally, we tested IL-10 production in peripheral blood mononuclear cells stimulated with @DISEASE$ and found that @GENE$ carriers produced lower levels of IL-10 when compared with non-carriers.", "text_with_entity_marker": "Finally, we tested IL-10 production in peripheral blood mononuclear cells stimulated with [E1]@DISEASE$[/E1] and found that [E2]@GENE$[/E2] carriers produced lower levels of IL-10 when compared with non-carriers.", "text_with_typed_entity_marker": "Finally, we tested IL-10 production in peripheral blood mononuclear cells stimulated with [DISEASE]@DISEASE$[/DISEASE] and found that [GENE]@GENE$[/GENE] carriers produced lower levels of IL-10 when compared with non-carriers.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [90, 99], "entity_1_idx_in_text_with_entity_marker": [94, 103], "entity_1_idx_in_text_with_typed_entity_marker": [99, 108], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [115, 121], "entity_2_idx_in_text_with_entity_marker": [128, 134], "entity_2_idx_in_text_with_typed_entity_marker": [140, 146], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_2_214", "text": "Our results suggested that common genetic variants in @GENE$ may modulate the risk of developing @DISEASE$ in the study population, particularly in non-smokers.", "text_with_entity_marker": "Our results suggested that common genetic variants in [E1]@GENE$[/E1] may modulate the risk of developing [E2]@DISEASE$[/E2] in the study population, particularly in non-smokers.", "text_with_typed_entity_marker": "Our results suggested that common genetic variants in [GENE]@GENE$[/GENE] may modulate the risk of developing [DISEASE]@DISEASE$[/DISEASE] in the study population, particularly in non-smokers.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [54, 60], "entity_1_idx_in_text_with_entity_marker": [58, 64], "entity_1_idx_in_text_with_typed_entity_marker": [60, 66], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [97, 106], "entity_2_idx_in_text_with_entity_marker": [110, 119], "entity_2_idx_in_text_with_typed_entity_marker": [119, 128], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_2_30", "text": "Toll-like receptor-induced @GENE$ secretion is impaired in @DISEASE$ by nucleotide oligomerization domain 2-dependent and -independent pathways.", "text_with_entity_marker": "Toll-like receptor-induced [E1]@GENE$[/E1] secretion is impaired in [E2]@DISEASE$[/E2] by nucleotide oligomerization domain 2-dependent and -independent pathways.", "text_with_typed_entity_marker": "Toll-like receptor-induced [GENE]@GENE$[/GENE] secretion is impaired in [DISEASE]@DISEASE$[/DISEASE] by nucleotide oligomerization domain 2-dependent and -independent pathways.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [27, 33], "entity_1_idx_in_text_with_entity_marker": [31, 37], "entity_1_idx_in_text_with_typed_entity_marker": [33, 39], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [59, 68], "entity_2_idx_in_text_with_entity_marker": [72, 81], "entity_2_idx_in_text_with_typed_entity_marker": [81, 90], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_2_27", "text": "The @GENE$ gene at 7q22.1 has been shown to be associated with familial @DISEASE$ (IAs) in the Japanese population.", "text_with_entity_marker": "The [E1]@GENE$[/E1] gene at 7q22.1 has been shown to be associated with familial [E2]@DISEASE$[/E2] (IAs) in the Japanese population.", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] gene at 7q22.1 has been shown to be associated with familial [DISEASE]@DISEASE$[/DISEASE] (IAs) in the Japanese population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [72, 81], "entity_2_idx_in_text_with_entity_marker": [85, 94], "entity_2_idx_in_text_with_typed_entity_marker": [94, 103], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_2_109", "text": "Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, @GENE$, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_entity_marker": "Two hundred and twenty-three incident [E1]@DISEASE$[/E1] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, [E2]@GENE$[/E2], RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_typed_entity_marker": "Two hundred and twenty-three incident [DISEASE]@DISEASE$[/DISEASE] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, [GENE]@GENE$[/GENE], RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [38, 47], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 56], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [451, 457], "entity_2_idx_in_text_with_entity_marker": [464, 470], "entity_2_idx_in_text_with_typed_entity_marker": [476, 482], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_2_229", "text": "Lack of association between @GENE$ and NOS1AP rs7538490 and @DISEASE$, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.", "text_with_entity_marker": "Lack of association between [E1]@GENE$[/E1] and NOS1AP rs7538490 and [E2]@DISEASE$[/E2], overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.", "text_with_typed_entity_marker": "Lack of association between [GENE]@GENE$[/GENE] and NOS1AP rs7538490 and [DISEASE]@DISEASE$[/DISEASE], overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [28, 34], "entity_1_idx_in_text_with_entity_marker": [32, 38], "entity_1_idx_in_text_with_typed_entity_marker": [34, 40], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [60, 69], "entity_2_idx_in_text_with_entity_marker": [73, 82], "entity_2_idx_in_text_with_typed_entity_marker": [82, 91], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_2_154", "text": "Association of variants of the @GENE$ gene with susceptibility to @DISEASE$.", "text_with_entity_marker": "Association of variants of the [E1]@GENE$[/E1] gene with susceptibility to [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Association of variants of the [GENE]@GENE$[/GENE] gene with susceptibility to [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [31, 37], "entity_1_idx_in_text_with_entity_marker": [35, 41], "entity_1_idx_in_text_with_typed_entity_marker": [37, 43], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [66, 75], "entity_2_idx_in_text_with_entity_marker": [79, 88], "entity_2_idx_in_text_with_typed_entity_marker": [88, 97], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_2_161", "text": "Recently an association was shown between the single nucleotide polymorphism (SNP), rs11209026, within the interleukin-23 receptor (@GENE$) locus and Crohn's disease (@DISEASE$) as a consequence of a genome-wide association study of this disease in adults.", "text_with_entity_marker": "Recently an association was shown between the single nucleotide polymorphism (SNP), rs11209026, within the interleukin-23 receptor ([E1]@GENE$[/E1]) locus and Crohn's disease ([E2]@DISEASE$[/E2]) as a consequence of a genome-wide association study of this disease in adults.", "text_with_typed_entity_marker": "Recently an association was shown between the single nucleotide polymorphism (SNP), rs11209026, within the interleukin-23 receptor ([GENE]@GENE$[/GENE]) locus and Crohn's disease ([DISEASE]@DISEASE$[/DISEASE]) as a consequence of a genome-wide association study of this disease in adults.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [132, 138], "entity_1_idx_in_text_with_entity_marker": [136, 142], "entity_1_idx_in_text_with_typed_entity_marker": [138, 144], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [167, 176], "entity_2_idx_in_text_with_entity_marker": [180, 189], "entity_2_idx_in_text_with_typed_entity_marker": [189, 198], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_2_283", "text": "The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (@GENE$ gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and @DISEASE$.", "text_with_entity_marker": "The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase ([E1]@GENE$[/E1] gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase ([GENE]@GENE$[/GENE] gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [80, 86], "entity_1_idx_in_text_with_entity_marker": [84, 90], "entity_1_idx_in_text_with_typed_entity_marker": [86, 92], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [216, 225], "entity_2_idx_in_text_with_entity_marker": [229, 238], "entity_2_idx_in_text_with_typed_entity_marker": [238, 247], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_2_91", "text": "Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of @GENE$ but protects against @DISEASE$.", "text_with_entity_marker": "Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of [E1]@GENE$[/E1] but protects against [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of [GENE]@GENE$[/GENE] but protects against [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [97, 103], "entity_1_idx_in_text_with_entity_marker": [101, 107], "entity_1_idx_in_text_with_typed_entity_marker": [103, 109], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [125, 134], "entity_2_idx_in_text_with_entity_marker": [138, 147], "entity_2_idx_in_text_with_typed_entity_marker": [147, 156], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_2_316", "text": "We genotyped the four single-nucleotide polymorphisms (rs706778, @GENE$, ss52580101, and rs11594656) of the IL2RA in 885 patients with @DISEASE$ and 606 control subjects of Japanese origin.", "text_with_entity_marker": "We genotyped the four single-nucleotide polymorphisms (rs706778, [E1]@GENE$[/E1], ss52580101, and rs11594656) of the IL2RA in 885 patients with [E2]@DISEASE$[/E2] and 606 control subjects of Japanese origin.", "text_with_typed_entity_marker": "We genotyped the four single-nucleotide polymorphisms (rs706778, [GENE]@GENE$[/GENE], ss52580101, and rs11594656) of the IL2RA in 885 patients with [DISEASE]@DISEASE$[/DISEASE] and 606 control subjects of Japanese origin.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [65, 71], "entity_1_idx_in_text_with_entity_marker": [69, 75], "entity_1_idx_in_text_with_typed_entity_marker": [71, 77], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [135, 144], "entity_2_idx_in_text_with_entity_marker": [148, 157], "entity_2_idx_in_text_with_typed_entity_marker": [157, 166], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_2_7", "text": "In humans, loss-of-function of the cilia-centrosomal protein @GENE$ is associated with @DISEASE$ and Meckel syndromes, whereas hypomorphic mutations result in Leber congenital amaurosis (LCA), a form of early-onset retinal dystrophy.", "text_with_entity_marker": "In humans, loss-of-function of the cilia-centrosomal protein [E1]@GENE$[/E1] is associated with [E2]@DISEASE$[/E2] and Meckel syndromes, whereas hypomorphic mutations result in Leber congenital amaurosis (LCA), a form of early-onset retinal dystrophy.", "text_with_typed_entity_marker": "In humans, loss-of-function of the cilia-centrosomal protein [GENE]@GENE$[/GENE] is associated with [DISEASE]@DISEASE$[/DISEASE] and Meckel syndromes, whereas hypomorphic mutations result in Leber congenital amaurosis (LCA), a form of early-onset retinal dystrophy.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [61, 67], "entity_1_idx_in_text_with_entity_marker": [65, 71], "entity_1_idx_in_text_with_typed_entity_marker": [67, 73], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [87, 96], "entity_2_idx_in_text_with_entity_marker": [100, 109], "entity_2_idx_in_text_with_typed_entity_marker": [109, 118], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_2_227", "text": "The @GENE$ and the T-allele of NOS1AP rs7538490 are reported to strongly associate with @DISEASE$ in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.", "text_with_entity_marker": "The [E1]@GENE$[/E1] and the T-allele of NOS1AP rs7538490 are reported to strongly associate with [E2]@DISEASE$[/E2] in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] and the T-allele of NOS1AP rs7538490 are reported to strongly associate with [DISEASE]@DISEASE$[/DISEASE] in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [88, 97], "entity_2_idx_in_text_with_entity_marker": [101, 110], "entity_2_idx_in_text_with_typed_entity_marker": [110, 119], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_2_13", "text": "@GENE$ was expressed in 60% and VEGFR-1 in 39% of @DISEASE$ specimens.", "text_with_entity_marker": "[E1]@GENE$[/E1] was expressed in 60% and VEGFR-1 in 39% of [E2]@DISEASE$[/E2] specimens.", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] was expressed in 60% and VEGFR-1 in 39% of [DISEASE]@DISEASE$[/DISEASE] specimens.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [50, 59], "entity_2_idx_in_text_with_entity_marker": [63, 72], "entity_2_idx_in_text_with_typed_entity_marker": [72, 81], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_2_59", "text": "A total of 180 patients with @DISEASE$ were categorized as high IL-1RA producers if they were carriers of at least one of the @GENE$ or rs579543 T/T genotypes (T/T carriers).", "text_with_entity_marker": "A total of 180 patients with [E1]@DISEASE$[/E1] were categorized as high IL-1RA producers if they were carriers of at least one of the [E2]@GENE$[/E2] or rs579543 T/T genotypes (T/T carriers).", "text_with_typed_entity_marker": "A total of 180 patients with [DISEASE]@DISEASE$[/DISEASE] were categorized as high IL-1RA producers if they were carriers of at least one of the [GENE]@GENE$[/GENE] or rs579543 T/T genotypes (T/T carriers).", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [29, 38], "entity_1_idx_in_text_with_entity_marker": [33, 42], "entity_1_idx_in_text_with_typed_entity_marker": [38, 47], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [126, 132], "entity_2_idx_in_text_with_entity_marker": [139, 145], "entity_2_idx_in_text_with_typed_entity_marker": [151, 157], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_2_261", "text": "Recently an association was shown between the single nucleotide polymorphism (SNP), @GENE$, within the interleukin-23 receptor (IL23R) locus and @DISEASE$ (CD) as a consequence of a genome-wide association study of this disease in adults.", "text_with_entity_marker": "Recently an association was shown between the single nucleotide polymorphism (SNP), [E1]@GENE$[/E1], within the interleukin-23 receptor (IL23R) locus and [E2]@DISEASE$[/E2] (CD) as a consequence of a genome-wide association study of this disease in adults.", "text_with_typed_entity_marker": "Recently an association was shown between the single nucleotide polymorphism (SNP), [GENE]@GENE$[/GENE], within the interleukin-23 receptor (IL23R) locus and [DISEASE]@DISEASE$[/DISEASE] (CD) as a consequence of a genome-wide association study of this disease in adults.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [84, 90], "entity_1_idx_in_text_with_entity_marker": [88, 94], "entity_1_idx_in_text_with_typed_entity_marker": [90, 96], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [145, 154], "entity_2_idx_in_text_with_entity_marker": [158, 167], "entity_2_idx_in_text_with_typed_entity_marker": [167, 176], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_2_281", "text": "STEC strains carrying @GENE$ were more frequently associated with clinical manifestations of hemolytic-uremic syndrome (HUS) or @DISEASE$ than those carrying stx2vha.", "text_with_entity_marker": "STEC strains carrying [E1]@GENE$[/E1] were more frequently associated with clinical manifestations of hemolytic-uremic syndrome (HUS) or [E2]@DISEASE$[/E2] than those carrying stx2vha.", "text_with_typed_entity_marker": "STEC strains carrying [GENE]@GENE$[/GENE] were more frequently associated with clinical manifestations of hemolytic-uremic syndrome (HUS) or [DISEASE]@DISEASE$[/DISEASE] than those carrying stx2vha.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [22, 28], "entity_1_idx_in_text_with_entity_marker": [26, 32], "entity_1_idx_in_text_with_typed_entity_marker": [28, 34], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [128, 137], "entity_2_idx_in_text_with_entity_marker": [141, 150], "entity_2_idx_in_text_with_typed_entity_marker": [150, 159], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_2_199", "text": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and @DISEASE$ in GPx1 and @GENE$ double knockout mice.", "text_with_entity_marker": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and [E1]@DISEASE$[/E1] in GPx1 and [E2]@GENE$[/E2] double knockout mice.", "text_with_typed_entity_marker": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and [DISEASE]@DISEASE$[/DISEASE] in GPx1 and [GENE]@GENE$[/GENE] double knockout mice.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [106, 115], "entity_1_idx_in_text_with_entity_marker": [110, 119], "entity_1_idx_in_text_with_typed_entity_marker": [115, 124], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [128, 134], "entity_2_idx_in_text_with_entity_marker": [141, 147], "entity_2_idx_in_text_with_typed_entity_marker": [153, 159], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_2_289", "text": "Additionally, the PKLR and the @GENE$ genotypes were demonstrated not to have a major influence on @DISEASE$.", "text_with_entity_marker": "Additionally, the PKLR and the [E1]@GENE$[/E1] genotypes were demonstrated not to have a major influence on [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Additionally, the PKLR and the [GENE]@GENE$[/GENE] genotypes were demonstrated not to have a major influence on [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [31, 37], "entity_1_idx_in_text_with_entity_marker": [35, 41], "entity_1_idx_in_text_with_typed_entity_marker": [37, 43], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [99, 108], "entity_2_idx_in_text_with_entity_marker": [112, 121], "entity_2_idx_in_text_with_typed_entity_marker": [121, 130], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
